Biologics are more effective at treating adult-onset Still’s disease (AOSD) than are glucocorticoids or conventional disease-modifying antirheumatic drugs (DMARDs), according to a new retrospective ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo-controlled ...

2023 marks 25 years since the approval of the first biologic drug in rheumatology. In this Viewpoint, five rheumatology researchers discuss how biologic therapy has transformed clinical practice, ...

Combination endoscopic sinus surgery (ESS) and biological therapy significantly decreased polyp burden in refractory chronic rhinosinusitis with nasal polyposis (CRSwNP) compared with biologic therapy ...

The American College of Chest Physicians ® (CHEST) recently released a new clinical guideline on biologic management in ...

There were 6137 AEs (84.9%) associated with biologic monotherapy and 1093 AEs (15.1%) associated with combined biologic therapy with MTX. The incidence rate for infections among patients treated with ...

Please provide your email address to receive an email when new articles are posted on . Among patients with inflammatory bowel disease who received at least two biologic therapies, discontinuation of ...

Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and ...

Most patients taking a biologic stayed on the therapy, and most saw decreases in exacerbations, a new study has found. The expanding availability of biologics to treat severe asthma has resulted in a ...

A 46-year-old man presents for his first dermatology consultation for worsening symptoms of plaque psoriasis and recent-onset joint pain. He reports “painful aching” and swelling of his finger joints, ...